down arrow

Jubilant Ingrev.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0BY001018
  • NSEID: JUBLINGREA
  • BSEID: 543271
INR
630.10
29.75 (4.96%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.77 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

609.70637.15

52 Week

461.70884.95
Valuation
Technical
Day's Volume

CASH

1.77 lacs (2.92%) Volume

Shareholding (Dec 2024)

FII

6.89%

Held by 109 FIIs

DII

15.99%

Held by 22 DIIs

Promoter

51.47%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of -1.06% and Operating profit at -23.51% over the last 5 years

 
2

Stock is technically in a Bearish range

3

With ROCE of 7.8, it has a Expensive valuation with a 2.9 Enterprise value to Capital Employed

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 10,036 Cr (Mid Cap)

stock-summary
P/E

46.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.83%

stock-summary
Debt Equity

0.23

stock-summary
Return on Equity

6.24%

stock-summary
Price to Book

3.40

Revenue and Profits (1 Year):
Net Sales:
1,057 Cr
(Quarterly Results - Dec 2024)
Net Profit:
69 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.83%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-14.28%
0.37%
-13.91%
1 Year
16.15%
0.92%
17.07%
2 Years
61.83%
2.33%
64.16%
3 Years
22.71%
2.97%
25.68%
4 Years
88.26%
3.63%
91.89%
5 Years
0%
0%
0.0%

Latest dividend: 2.5 per share ex-dividend date: Feb-03-2025

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-1.06%
EBIT Growth (5y)
-23.51%
EBIT to Interest (avg)
13.74
Debt to EBITDA (avg)
1.48
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.28
Tax Ratio
29.61%
Dividend Payout Ratio
43.19%
Pledged Shares
2.71%
Institutional Holding
22.89%
ROCE (avg)
13.90%
ROE (avg)
9.99%
Valuation key factors
Factor
Value
P/E Ratio
46
Industry P/E
33
Price to Book Value
3.40
EV to EBIT
33.00
EV to EBITDA
22.04
EV to Capital Employed
2.94
EV to Sales
2.43
PEG Ratio
46.34
Dividend Yield
0.83%
ROCE (Latest)
7.85%
ROE (Latest)
6.24%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

2.7138

Mutual Funds

Held by 17 Schemes (13.91%)

FIIs

Held by 109 FIIs (6.89%)

Promoter with highest holding

Spb Trustee Company Pl & Ss Trustee Company Pl (20.63%)

Highest Public shareholder

Dsp Small Cap Fund (9.52%)

Individual Investors Holdings

19.17%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 1.10% vs 2.04% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 17.59% vs 21.05% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,056.77",
          "val2": "1,045.24",
          "chgp": "1.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "138.29",
          "val2": "124.57",
          "chgp": "11.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.39",
          "val2": "15.07",
          "chgp": "-17.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "69.38",
          "val2": "59.00",
          "chgp": "17.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.22%",
          "val2": "12.11%",
          "chgp": "1.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -1.21% vs -15.16% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -6.38% vs -29.68% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,069.58",
          "val2": "2,094.96",
          "chgp": "-1.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "234.10",
          "val2": "234.31",
          "chgp": "-0.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "29.34",
          "val2": "23.98",
          "chgp": "22.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "107.74",
          "val2": "115.08",
          "chgp": "-6.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.48%",
          "val2": "11.27%",
          "chgp": "0.21%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 2.12% vs -15.61% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 15.28% vs -39.79% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,126.35",
          "val2": "3,061.36",
          "chgp": "2.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "372.39",
          "val2": "329.88",
          "chgp": "12.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "41.73",
          "val2": "39.04",
          "chgp": "6.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "177.12",
          "val2": "153.64",
          "chgp": "15.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.91%",
          "val2": "10.78%",
          "chgp": "1.13%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -13.34% vs -3.57% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -40.52% vs -35.50% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,135.80",
          "val2": "4,772.69",
          "chgp": "-13.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "421.12",
          "val2": "547.14",
          "chgp": "-23.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "52.66",
          "val2": "21.58",
          "chgp": "144.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "182.89",
          "val2": "307.50",
          "chgp": "-40.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.27%",
          "val2": "11.54%",
          "chgp": "-1.27%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
1,056.77
1,045.24
1.10%
Operating Profit (PBDIT) excl Other Income
138.29
124.57
11.01%
Interest
12.39
15.07
-17.78%
Exceptional Items
0.00
0.00
Consolidate Net Profit
69.38
59.00
17.59%
Operating Profit Margin (Excl OI)
13.22%
12.11%
1.11%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 1.10% vs 2.04% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 17.59% vs 21.05% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
2,069.58
2,094.96
-1.21%
Operating Profit (PBDIT) excl Other Income
234.10
234.31
-0.09%
Interest
29.34
23.98
22.35%
Exceptional Items
0.00
0.00
Consolidate Net Profit
107.74
115.08
-6.38%
Operating Profit Margin (Excl OI)
11.48%
11.27%
0.21%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -1.21% vs -15.16% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -6.38% vs -29.68% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3,126.35
3,061.36
2.12%
Operating Profit (PBDIT) excl Other Income
372.39
329.88
12.89%
Interest
41.73
39.04
6.89%
Exceptional Items
0.00
0.00
Consolidate Net Profit
177.12
153.64
15.28%
Operating Profit Margin (Excl OI)
11.91%
10.78%
1.13%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 2.12% vs -15.61% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 15.28% vs -39.79% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
4,135.80
4,772.69
-13.34%
Operating Profit (PBDIT) excl Other Income
421.12
547.14
-23.03%
Interest
52.66
21.58
144.02%
Exceptional Items
0.00
0.00
Consolidate Net Profit
182.89
307.50
-40.52%
Operating Profit Margin (Excl OI)
10.27%
11.54%
-1.27%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -13.34% vs -3.57% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -40.52% vs -35.50% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Jubilant Ingrevia Ltd stock-summary
stock-summary
Jubilant Ingrevia Ltd
Mid Cap
Pharmaceuticals & Drugs
Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on 23 October 2019 in Uttar Pradesh. The name of Company was changed from 'Jubilant LSI Limited' to 'Jubilant Ingrevia Limited' effective October 16, 2020.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."